Insurance linked to black-white survival disparities in colorectal cancerNovember 14, 2017
Health insurance coverage differences account for nearly one-half of the black-white survival disparity in colorectal cancer patients, according to a new study. The study, published in Gastroenterology, reinforces the importance of equitable health insurance coverage to mitigate the black-white survival disparity in colorectal cancer.
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in both men and women in the United Sates. Overall CRC incidence and mortality rates are decreasing in the United States as a result of earlier detection and improved treatments. Nonetheless, CRC incidence and mortality rates continue to be higher in blacks than in whites.
For the new study, investigators led by Helmneh Sineshaw, M.D., MPH, at the American Cancer Society with collaborators from Dana-Farber Cancer Institute at Harvard Medical School, focused on the impact of access to care on black-white survival disparity. They looked at 199,098 CRC patients ages 18 to 64 in the National Cancer Database.
They found the absolute 5-year survival difference between black and white CRC patients in the entire cohort was 9.2% (57.3% vs 66.5%). That difference was cut almost in half, to 4.9%, after matching for insurance status. Tumor characteristics also played a large role. The survival difference dropped to 2.3% after tumor characteristics matching.
"These findings reinforce the importance of equitable health insurance coverage to mitigate the survival disparity between black versus white CRC patients in this age range, and underscore the need for further studies to elucidate reasons for racial differences in tumor characteristics," write the authors.
In October, an American Cancer Society study found that differences in insurance explained one-third of the black-white difference in women with early-stage breast cancer.
URL upon publication: http://dx.doi.org/10.1053/j.gastro.2017.11.005
American Cancer Society
Related Colorectal Cancer Articles:
A highly sensitive method that can detect even the earlier stages of colorectal cancer has been developed by researchers in Japan.
Colorectal cancer is the fourth most common type of cancer in the United States, with nearly 135,000 cases reported in 2016.
Despite dramatic reductions in overall colorectal cancer incidence and mortality, striking disparities by age, race, and tumor subsite remain
While many patients with colorectal are diagnosed when they are older than 50, about 10 percent of patients are diagnosed at younger ages.
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
Sanford Health has opened another clinical trial exploring the power of the body's immune system to fight cancer.
Selenium has been a popular nutritional supplement for decades, touted for its antioxidant properties and its role in stopping free radicals from damaging cells and DNA.
Bacteria commonly found in the mouth have been recently shown to worsen colorectal cancer in animals, but it has not been clear how these microbes make their way to the gut in the first place.
An emerging cancer therapy has colorectal tumors surrounded. Presenters at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging are unveiling a novel radioimmunotherapy that combines a cancer-seeking antibody with potent radionuclide agents, resulting in complete remission of colorectal cancer in mouse models.
University of Colorado Cancer Center study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2016 finds that in patients over 50, the rate of CRC is falling at 2.5 percent per year while the rate of CRC in patients under 50 is rising at 0.8 percent per year.
Related Colorectal Cancer Reading:
American Cancer Society's Complete Guide to Colorectal Caner
by American Cancer Society (Author)
Don't die of embarrassment--get informed about colorectal cancer
Although colorectal cancer is the third most common cancer found in men and women, you may be unaware of your risk and don't know what you can do to prevent this serious disease. You may be too embarrassed to ask your doctor about changes in your bowel habits or get screened for colorectal cancer. American Cancer Society's Complete Guide to Colorectal Cancer provides sound information and support if you are concerned about or diagnosed with colorectal cancer.
Written by experts in oncology,... View Details
Colorectal Cancer (Oxford Oncology Library)
by Daniel Swinson (Author), Matthew Seymour (Author)
Colorectal cancer is one of the leading causes of cancer-related death in the world. Twenty-five percent of patients present with advanced disease and, despite complete surgical resection of early stage disease, 50% of patients relapse. The treatment of colorectal cancer has advanced rapidly in recent years, and controversies persist regarding optimal management (e.g. whether combination chemotherapy should be used first-line or in a staged fashion, how long to treat patients for and whether to use an intermittent or continuous schedule and whether to refer for a radical approach for advanced... View Details
Be a Survivor - Colorectal Cancer Treatment Guide
by Vladimir Lange (Author)
This much-needed colorectal cancer resource is developed in consultation with a large national team of experts and endorsed not only by the American Society of Colon and Rectal Surgeons but also by the National non-profit the Colon Cancer Alliance. As with all of the Be a Survivor resources this book features candid testimonials by survivors. It is straightforward, easy-to-understand and contains objective and up-to-date information. The beautiful color photos and graphics enhance the learning process. Most importantly the book leaves the reader with a message of hope. The book addresses each... View Details
Colorectal Cancer: From Pathogenesis to Prevention?
by Helmut K. Seitz (Editor), Ulrich A. Simanowski (Editor), Nicholas A. Wright (Editor), B.C. Morson (Editor)
The past 20 years have seen a surge of research into colorectal cancer, which is a reflection of the need to improve our methods of treating patients suffering from this increasingly common form of cancer. Greater knowledge of the basic mechanisms involved in colorectal carcinogenesis is an essential prerequisite to improvements in cancer prevention. In this volume the editors have brought together an impressive list of experts to cover the epidemiology, pathophysiology, morphology and basis for new diagnostic and therapeutic approaches to early detection and prevention. This broad scientific... View Details
The Colon Cancer Diet
by Dr. Christopher J. Maloney N.D. (Author)
Do you have colon cancer? Does someone you love? Did you know that eating differently, even after you are diagnosed, can lower your risk of dying? When you finish this book I want you to be able to tell me, in a minute or less, how you should eat, exercise, and supplement to lower your risk of dying as a diagnosed colon cancer patient. Last year when I when I was diagnosed I went looking for this book. With all the diet books, I figured someone had written a book specifically for newly diagnosed colon cancer patients. But there was nothing. I checked with my doctors and with the... View Details
Molecular Pathogenesis of Colorectal Cancer
by Kevin M. Haigis Ph.D. (Editor)
Colorectal cancer has for more than two decades served as the paradigm for the multi-step concept of cancer initiation and progression. Perhaps more than any other organ site, cancer of the colon is extensively characterized at the molecular level. We are now entering a time when molecular classification, rather than histologic classification, of cancer subtypes is driving the development of clinical trials with emerging targeted therapies. The book will focus on the progression from the identification of mutations that drive colorectal cancer initiation and progression to the search for... View Details
Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)
by Leonard B. Saltz (Editor)
Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and others are in the late phases of clinical development. Likewise, surgical and ablative options, as well as an array of supportive medications, have shown substantial progress and undergone a dramatic proliferation over the past decade. With the increased number of therapeutic options from which to... View Details
What Your Doctor May Not Tell You About(TM) Colorectal Cancer: New Tests, New Treatments, New Hope (What Your Doctor May Not Tell You About...(Paperback))
by Mark Bennett Pochapin (Author)
- What Your Doctor May Not Tell You About Colorectal Cancer was published in Warner hardcover (0-446-53188-X) in 3/04. The book features a foreword by Katie Couric.
- Dr. Pochapin made an appearance on the Today show in conjunction with the hardcover publication of this book. Previously, he had been chosen by Katie Couric to be the Medical Director of the Jay Monahan Center for Gastrointestinal Health, named in honor of Ms. Couric's late husband.
- The author is an associate professor of clinical medicine at the Weill Medical College of Cornell University and Chief of Gastrointestinal... View Details
Semi-Colon: A Writer's Cheeky Journey Through Colorectal Cancer
by Neil Crone (Author)
This unique, funny and uplifting collection of emails, newspaper articles and quotes shares Canadian actor, comedian and writer, Neil Crone's journey through colorectal cancer. This is a must-have for anyone going through cancer treatment, anyone who knows someone going through treatment, or anyone who just wants an insightful read about life. View Details
Surgical Treatment of Colorectal Cancer: Asian Perspectives on Optimization and Standardization
by Nam Kyu Kim (Editor), Kenichi Sugihara (Editor), Jin-Tung Liang (Editor)
This book presents an Asian perspective on how the treatment of colorectal cancer can be optimized and standardized in ways that take into account technological advances and the trend towards individually tailored therapy. Readers will find careful, well-illustrated descriptions of the standard surgical techniques for rectal cancer and colon cancer that have contributed to recent improvements in 5-year survival rates in the Asia-Pacific region, where the incidence of colorectal cancer has been rising alarmingly due to lifestyle changes. The vital role now being played by minimally... View Details